Intuitive Surgical executive Mark Brosius sold 48 shares in two transactions at prices ranging from $347.66 to $365.79 per share on 2026-09-10 and 2026-09-11. The activity matters to investors because both transactions used code S, identifying open-market sales by the company’s executive vice president.
Key Highlights
- The transactions occurred on 10 September 2026 and 11 September 2026.
- Both sales carried transaction code S.
- Mark Brosius serves as EVP and Chief Mfg and Supply Cha at Intuitive Surgical.
INTUITIVE SURGICAL INC (NASDAQ: ISRG) executive Mark Brosius sold 48 shares across two transactions priced from $347.66 to $365.79 per share. The transactions took place on 10 September 2026 and 11 September 2026. The sales were made by Brosius in his role as EVP and Chief Mfg and Supply Cha. Both transactions used code S.
Two Transactions at Different Prices
The reported price range ran from $347.66 to $365.79 per share. The activity was split between two separate transactions across the two dates. Each transaction involved Intuitive Surgical common shares sold by Brosius. The transaction code applied to both entries was S. The transactions therefore record share sales by a company executive over the two dates.
FAQs
Q: What did Mark Brosius sell at Intuitive Surgical?
A: Mark Brosius sold 48 Intuitive Surgical shares in two transactions. The reported prices ranged from $347.66 to $365.79 per share.
Q: What does the Intuitive Surgical insider sale mean for the stock?
A: The filing reports that an Intuitive Surgical executive sold shares in two transactions.
Q: When did the Intuitive Surgical share sales occur?
A: The filing reports that Mark Brosius sold Intuitive Surgical shares in two transactions dated 10 September 2026 and 11 September 2026. Together, the transactions covered 48 shares at prices ranging from $347.66 to $365.79 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.